- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04113252
Impact of Coaching Patients on Pain Control With and Without Financial Incentivization
The Economy of Pain: A Pilot Study of the Impact of an Opioid Buyback Program
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study participants will receive the standard of care for pain management at discharge. If study participants were not hospitalized at discharge, the study team will begin that standard of pain management at the participant's first outpatient clinic visit. Study participants will be randomized to 1 of 3 groups. All groups will receive a gift card if participants return the completed medication diary to the study team.
- Group 1 will complete a medication diary. Also, group 1 will be encouraged to return any unused tablets to the study clinic.
- Group 2 will be asked to complete a medication diary. Group 2 will also have a 50/50 chance of receiving money for each unused opioid tablet returned to the study clinic.
- Group 3 will be the same as group 2 except in addition, they will be given a coaching session about the use of pain medication and a simple way that may help participants use less opioid pain medication.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients suffering from a burn injury of one or both hands/upper extremities
- Patients staying less than 2 midnights after date of injury or presenting for first visit to the clinic 4 or less days after injury
- Patients able to self-administer their oxycodone.
- Aged 18-89 years old
Exclusion Criteria:
- No burns on either hand or upper extremity
- Patients suffering chemical or electrical burns
- Patients with other traumatic injuries for which they might require opioids/pain treatment
- Patients taking opioids prior to injury
- Patients who are discharged with prescriptions other than oxycodone with a dosage of 5 milligrams by mouth every six hours as needed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1--Diary and Possible Opioid Return Incentive
Participants in this arm will be given incentives upon return of completed diary and will have the possibility to earn incentives for returning any leftover tablets to the study team.
|
Subjects who return completed diary will have the possibility to receive money for returned opioid tablets.
Subjects who return completed diary will receive a gift card.
|
Experimental: Group 2--Diary, Coaching, Possible Opioid Return Incentive
Participants in this arm will be given coaching.
They will also be given incentives upon return of completed diary and will have the possibility to earn incentives for returning any leftover tablets to the study team.
|
Subjects who return completed diary will have the possibility to receive money for returned opioid tablets.
Subjects who return completed diary will receive a gift card.
Subjects will receive coaching prior to starting pain medication.
|
Experimental: Group 3--Diary and coaching
Participants in this arm will be given coaching.
They will also be given incentives upon return of completed diary.
|
Subjects who return completed diary will receive a gift card.
Subjects will receive coaching prior to starting pain medication.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean number of opioid tablets used daily
Time Frame: up through two weeks
|
up through two weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: John K Bailey, MD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00058073
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Use
-
Sharon WalshNational Institute on Drug Abuse (NIDA)Completed
-
Aurora Health CareUniversity of Chicago; University of California, Santa Cruz; Rogers Behavioral...RecruitingSubstance Use | Methamphetamine-dependence | Opioid Use | Opioid-use Disorder | Cocaine Use Disorder | Cocaine Use | Methamphetamine AbuseUnited States
-
Indonesia UniversityRecruiting
-
Lawson Health Research InstituteNot yet recruiting
-
University of Colorado, DenverUniversity of Nebraska; Agency for Healthcare Research and Quality (AHRQ)Completed
-
Zulekha HospitalsCompleted
-
Peking University People's HospitalCompleted
-
University of UtahCompleted
-
University Health Network, TorontoOntario Ministry of Health and Long Term CareCompleted
Clinical Trials on Possible Incentive for Tablet Return
-
Centre Hospitalier Universitaire DijonRecruiting
-
National University of SingaporeCompletedHealth Knowledge, Attitudes, Practice | Weight ReductionSingapore
-
University of PennsylvaniaCompleted
-
Tulane UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedCOVID-19 | Colorectal Cancer | Influenza | Health Behavior | Vaccine-Preventable Diseases | Vaccine Hesitancy | Healthcare Patient AcceptanceUnited States
-
Clinique Romande de ReadaptationUniversity of Applied Sciences of Western SwitzerlandCompleted
-
University Health Network, TorontoThe Weston A. Price FoundationRecruitingChronic Traumatic EncephalopathyCanada
-
Carnegie Mellon UniversityUniversity of Pennsylvania; Rutgers UniversityCompletedControl - No Incentive for Flu Vaccine | Direct Incentive | Indirect IncentiveUnited States
-
University Hospital, LimogesCompleted
-
Harvard Medical School (HMS and HSDM)University of California, Berkeley; University of Southern CaliforniaWithdrawnReceipt of Radiology Studies | Receipt of Laboratory Tests
-
University of Wisconsin, MadisonCompletedSmoking | Smoking Cessation | Nicotine DependenceUnited States